🚨 DEADLINE EXTENDED! Your science in the spotlight! 🚨
The Call for Science & Cases for the inaugural Complex Coronary Summit (CCS) in Miami has been extended until THIS FRIDAY! 🔥
📢 Don’t miss your chance to submit!
📍 Miami, January 20–22
🌴 See you all in Miami for the FIRST Complex Coronary Summit!
@solaci_online@crfheart@sbhci@SOCiME_@smexcardiologia@CACIarg
#CCSMiami #ComplexPCI #InterventionalCardiology #CoronaryInterventions #CardioTwitter
PCR Perspectives: CT angiography beyond traditional risk factors
📺 & 🎧https://t.co/wEVSammLLW
@rajani_dr and @ColletCarlos discuss the role of coronary CT angiography in cardiovascular risk assessment among asymptomatic individuals. They review current approaches to risk stratification and examine whether imaging can provide incremental value beyond traditional clinical risk factors.
Also available as a podcast!
#interventionalcardiology #EuroPCR #cardioed
When I moved from full-time academic practice to industry, I had many of the same questions I now hear from colleagues.
Looking forward to joining @SCAI tomorrow to discuss opportunities beyond the cath lab and how to get started.
Join us!
Coronary CT #CCTA takes center stage at #TCT2026!
A mobile CT scanner right in the Expo Hall, where attendees are undergoing coronary CT scans with real-time analysis using @HeartFlow technology.
Bringing the future of CT-guided PCI directly to TCT!
P4 at #TCT2026: Can CT guide PCI?
1,100 patients, CCTA- vs IVUS-guided PCI:
• 1-year TVF: 4.1% vs 4.6%
• Non-inferiority achieved
• 17 min shorter procedural time
• 20 mL less contrast
Dr Carlos Collet in conversation with @drnvanmieghem
“Before you put your foot on the pedal, you already know what you’re going to see.”
▶️ Watch the discussion: https://t.co/fldqAOKWt2
#TCT2026 #P4Trial #PCI #CCTA #IVUS #CoronaryCT #InterventionalCardiology #Cardiology #CardioTwitter
Dr. Carlos Collet and Dr. C. Michael Gibson discuss the P4 Trial: Comprehensive CCTA-guided PCI strategy was associated with a lower rate of target vessel failure at 12 months compared to IVUS-guided PCI (4.1% vs. 4.8%) among patients with chronic coronary syndrome or stabilized acute coronary syndrome, supporting procedural safety and non-inferiority.
Watch video here: https://t.co/Lxy2Ud5E36
Presented at #TCT2026:
In a randomized trial, CCTA-guided PCI with structured preprocedural planning and intraprocedural guidance was noninferior to intravascular ultrasound–guided PCI with respect to target-vessel failure at 12 months. Full P4 trial results: https://t.co/oTj4ZoERlv
@crfheart
Today, we unveil the P4 randomized trial
The main question:
Can CT-guided PCI achieve similar outcomes compared to IVUS-guided PCI?
Join us in the Main Arena at #TCT2026@crfheart
The stage is set, and we’re ready to welcome you to #TCT2026 tomorrow!
We are ready to what promises to be an exciting few days of groundbreaking science, innovation, and education.
#TCT2026#Cardiology#Innovation#CRF
🚨 AI in the cath lab. Aspiration devices in YOUR hands.
Don’t miss #TCT2026: explore the AI shaping our field and learn how to use aspiration devices in hands-on training. @crfheart@jgranadacrf
🎥 Abdallah El Sabbagh @aelsab joins me to give you a preview. Watch👇
Sharpen your imaging skills, try a new device or master a technique with an expert next to you!
We will have more than 50 hands on sessions #TCT2026 !!!